InspireMD (NYSEAMERICAN: NSPR) is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention.
Proprietary MicroNet mesh addresses the primary shortcomings and harmful consequences of conventional Carotid stenting and surgery. InspireMD seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for sustained embolic protection, neurovascular protection and stroke prevention.
InspireMD is focused on changing the carotid/neurovascular market through expanding its portfolio of solutions along with pursuing applications of its MicroNet technology in other indications such as peripheral artery procedures.
Mr. Slosman has over 30 years of experience in the medical device industry with focused leadership in commercialization and international market development in both public and privately held companies.
Prior to joining InspireMD, he served as a Business Consultant for Integra LifeSciences overseeing commercial strategy and market development for Integra’s international business. Before that, he served as President of ITAMAR Medical, a developer of cardiovascular and sleep diagnostic technologies. Prior to ITAMAR, Mr. Slosman served as Chief Executive Officer of Ovalum Vascular, Ltd., a privately held medical device company focused on vascular device innovations. Earlier in his career, Mr. Slosman served as Chief Executive Officer of Phormax Medical, Inc., Senior Executive Vice President and Chief Commercial Officer at Emerge Interactive in addition to senior commercial leadership positions at Johnson & Johnson, GE Healthcare and Baxter.
Mr. Slosman received a BS from The University of Alabama and an MBA from The University of Chicago.